...
首页> 外文期刊>Annals of clinical biochemistry. >Comparing glomerular filtration rate equations and the impact of different creatinine assays on the assessment of renal function in cancer patients
【24h】

Comparing glomerular filtration rate equations and the impact of different creatinine assays on the assessment of renal function in cancer patients

机译:比较肾小球过滤速率方程和不同肌酐测定对癌症患者肾功能评估的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background Equations to estimate glomerular filtration rate based on serum creatinine are commonly used in cancer patients to assess renal function. However, there is uncertainty regarding which equation is most appropriate for this population and the impact of different creatinine assays. Methods Measured isotopic glomerular filtration rate results from 120 oncology patients were used to evaluate and compare all four versions of the Wright equation, Cockcroft and Gault, Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration and the Janowitz and Williams formula; using eight different creatinine assays (five Jaffe, three enzymatic). Results The enzymatic version of the Wright equation without creatine kinase performed better than the other versions for all eight creatinine assays. However, MDRD and Janowitz and Williams gave the best overall performance in this patient population. Performance was highly dependent on the creatinine assay used, for example, the percentage of results within 30% of the isotopic glomerular filtration rate (P30) ranged from 90.8% to 60.8% for MDRD. Conclusion The performance of any equation to estimate glomerular filtration rate is highly dependent on the creatinine assay used. Oncology units should assess the performance of glomerular filtration rate equations using their laboratory creatinine assay to determine whether they can be used safely and effectively in cancer patients.
机译:基于血清肌酐的肾小球过滤速率常用于癌症患者以评估肾功能的背景方程。然而,关于哪种等式最适合这种群体和不同肌酸酐测定的影响存在不确定性。方法测量的同位素肾小球过滤速率来自120例肿瘤患者的赖特方程,Cockcroft和Gault的所有四种版本,肾病(MDRD),慢性肾病流行病学合作和Janowitz和Williams公式;使用八种不同的肌酸酐测定(五个jaffe,三种酶)。结果没有肌酸激酶的赖特方程的酶版本比所有八种肌酐测定的其他版本更好。但是,MDRD和Janowitz和Williams在这一患者人口中给出了最佳的整体表现。性能高度依赖于使用的肌酸酐测定,例如,在同位素肾小球过滤速率(P30)的30%以内的百分比范围为MDRD的90.8%至60.8%。结论任何等式以估计肾小球过滤速率的性能高度依赖于所用的肌酸酐测定。肿瘤学单位应使用其实验室肌酐测定评估肾小球过滤速率方程的性能,以确定它们是否可以在癌症患者中安全有效地使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号